Vietnam MOH registration 2403558ĐKLH/BYT-HTTB

Treponema pallidum antibody qualitative test reference standard drug

VN: Thuốc thử, chất hiệu chuẩn xét nghiệm định tính kháng thể kháng Treponema pallidum
Vietnam flagVietnam·Risk Class TTBYT Loại D·Theo theo phụ lục·Registered Nov 14, 2024
Registration details
Analysis ID
2403558ĐKLH/BYT-HTTB
Submission ID
18008064/ĐKLH-BYT-TB-CT
Product Type
Theo theo phụ lục
Product Code
Theo phụ lục
Company information
Authorized Representative
CÔNG TY TNHH ROCHE VIỆT NAM
Technical details
Intended Use
In vitro immunoassay for the qualitative determination of antibodies against Treponema pallidum in human serum and plasma. This test is used as a supportive diagnostic tool for syphilis. The ECLIA fluorescent immunoassay is used on the Elecsys and cobas e platforms.
Dates and status
Registration Date
Nov 14, 2024
About this record

Access comprehensive regulatory information for Treponema pallidum antibody qualitative test reference standard drug in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại D medical device is registered under number 2403558ĐKLH/BYT-HTTB. The authorized representative in Vietnam is CÔNG TY TNHH ROCHE VIỆT NAM.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI300,000+ Devices